<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000045435"><TermName>vincristine</TermName><TermPronunciation>(vin-KRIS-teen)</TermPronunciation><TermDefinition><DefinitionText>The active ingredient in a drug used to treat acute leukemia. It is used in combination with other drugs to treat Hodgkin disease, non-Hodgkin lymphoma, rhabdomyosarcoma, neuroblastoma, and Wilms tumor. Vincristine is also being studied in the treatment of other types of cancer. It blocks cell growth by stopping cell division. It is a type of vinca alkaloid and a type of antimitotic agent.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000705463" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;vincristine&quot;" language="en" id="_3"/><MediaLink ref="CDR0000705462" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;vincristina&quot;" language="es" id="_4"/><SpanishTermName>vincristina</SpanishTermName><SpanishTermDefinition><DefinitionText>Ingrediente activo de un medicamento que se usa para tratar la leucemia aguda. Se usa en combinación con otros medicamentos para tratar la enfermedad de Hodgkin, el linfoma no Hodgkin, el rabdomiosarcoma, el neuroblastoma y el tumor de Wilms. La vincristina también está en estudio para el tratamiento de otros tipos de cáncer. Bloquea la formación de células al impedir su multiplicación. Es un tipo de alcaloide de vinca y un tipo de antimitótico.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateLastModified>2008-09-18</DateLastModified></GlossaryTerm>
